United States · Platforms & data · Investing.com

Ligand Pharmaceuticals director sells $90,237 in common stock

Published by Investing.com · United States 1 h ago

Read the full article on Investing.com Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investing.com)

Also worth reading

Plains All American Pipeline (NASDAQ:PAA) Posts Quarterly Earnings Results, Misses Estimates By $0.44 EPS

Baytex targets 76,000-79,000 BOE/d in 2027 while outlining 8%-10% annual growth through 2029

‘I have no financial safety net’: I’m 66, rely on Social Security and have just $500 in savings. What hope do I have?

Nasdaq drops into correction territory — here’s what typically happens next

Tech Bounces, but the S&P 500 Still Has Its Worst Week Since April 2025

Adex Mining Adjourns Mount Pleasant Appeal to March 2027